Ketamine / Propofol Admixture

DRUG2 trials

Sponsors

Mayo Clinic, Assiut University

Conditions

CholangitisCritical IllnessPancreatitis

Phase 2

Ketamine / Propofol Admixture Ketofol at Induction in the Critically Ill Against Etomidate: KEEP PACE Trial

CompletedNCT02105415

Mayo ClinicCritical Illness

Start: 2014-04-30End: 2018-08-01Updated: 2020-06-16

Haemodynamic Stability of Ketamine/Propofol Admixture Ketofol in Patient Undergoing Endoscopic Retrograde Cholangio Pancreatography

TerminatedNCT02618668

Assiut UniversityCholangitis, Pancreatitis

Start: 2015-07-31End: 2018-09-30Updated: 2019-09-23

Related Papers

Association of Shock Indices with Peri-Intubation Hypotension and Other Outcomes: A Sub-Study of the KEEP PACE Trial

Journal of Intensive Care Medicine2024-02-256 citations

Ketamine/propofol admixture vs etomidate for intubation in the critically ill: KEEP PACE Randomized clinical trial

The Journal of Trauma: Injury, Infection, and Critical Care2019-07-1897 citations

Hemodynamic stability of ketamine/propofol admixture ketofol in patients undergoing endoscopic retrograde cholangiopancreatography

Journal of Current Medical Research and Practice2018-01-011 citations

Ketamine/propofol admixture (ketofol) at induction in the critically ill against etomidate (KEEP PACE trial): study protocol for a randomized controlled trial

Trials2015-04-2019 citations